Dr. Steven Reed joined the faculty of the Scripps Research Institute in 1986. He is currently professor of Molecular Medicine. Dr. Reed received a B.S. in Molecular Biophysics and Biochemistry from Yale University and a Ph.D. in Biochemistry from Stanford University. He then carried out postdoctoral work in Genetics with Leland Hartwell at the University of Washington. He was on the faculty of UCSB prior to joining the Scripps Research Institute. Dr. Reed’s major research focus has been in the areas of control of cell proliferation and cancer. This work ultimately led to the identification of a potential therapeutic target for treating chronic myelogenous leukemia and the drug discovery program that represents the core technology being developed by Xtem Pharmaceuticals. Dr. Reed is currently the Chief Scientific Officer of Xtem Pharmaceuticals.
Dr. Steven Reed, Ph.D.